This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaney, J. E.
Right arrow Articles by Whitehead, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaney, J. E., Jr.
Right arrow Articles by Whitehead, S. S.

 Previous Article  |  Next Article 

Journal of Virology, October 2001, p. 9731-9740, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9731-9740.2001

Chemical Mutagenesis of Dengue Virus Type 4 Yields Mutant Viruses Which Are Temperature Sensitive in Vero Cells or Human Liver Cells and Attenuated in Mice

Joseph E. Blaney Jr.,* Daniel H. Johnson, Cai-Yen Firestone, Christopher T. Hanson, Brian R. Murphy, and Stephen S. Whitehead

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892

Received 1 May 2001/Accepted 24 July 2001

A recombinant live attenuated dengue virus type 4 (DEN4) vaccine candidate, 2ADelta 30, was found previously to be generally well tolerated in humans, but a rash and an elevation of liver enzymes in the serum occurred in some vaccinees. 2ADelta 30, a non-temperature-sensitive (non-ts) virus, contains a 30-nucleotide deletion (Delta 30) in the 3' untranslated region (UTR) of the viral genome. In the present study, chemical mutagenesis of DEN4 was utilized to generate attenuating mutations which may be useful in further attenuation of the 2ADelta 30 candidate vaccine. Wild-type DEN4 2A virus was grown in Vero cells in the presence of 5-fluorouracil, and a panel of 1,248 clones were isolated. Twenty ts mutant viruses were identified that were ts in both simian Vero and human liver HuH-7 cells (n = 13) or only in HuH-7 cells (n = 7). Each of the 20 ts mutant viruses possessed an attenuation phenotype, as indicated by restricted replication in the brains of 7-day-old mice. The complete nucleotide sequence of the 20 ts mutant viruses identified nucleotide substitutions in structural and nonstructural genes as well as in the 5' and 3' UTRs, with more than one change occurring, in general, per mutant virus. A ts mutation in the NS3 protein (nucleotide position 4995) was introduced into a recombinant DEN4 virus possessing the Delta 30 deletion, thereby creating rDEN4Delta 30-4995, a recombinant virus which is ts and more attenuated than rDEN4Delta 30 virus in the brains of mice. We are assembling a menu of attenuating mutations that should be useful in generating satisfactorily attenuated recombinant dengue vaccine viruses and in increasing our understanding of the pathogenesis of dengue virus.

* Corresponding author. Mailing address: LID, NIAID, NIH, Bldg. 7, Room 100, 7 Center Dr. MSC 0720, Bethesda, MD 20892. Phone: (301) 402-7751. Fax: (301) 496-8312. E-mail: jblaney{at}niaid.nih.gov.

Journal of Virology, October 2001, p. 9731-9740, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9731-9740.2001


This article has been cited by other articles:

  • Rumyantsev, A. A., Murphy, B. R., Pletnev, A. G. (2006). A Tick-Borne Langat Virus Mutant That Is Temperature Sensitive and Host Range Restricted in Neuroblastoma Cells and Lacks Neuroinvasiveness for Immunodeficient Mice. J. Virol. 80: 1427-1439 [Abstract] [Full Text]  
  • Blaney, J. E. Jr., Matro, J. M., Murphy, B. R., Whitehead, S. S. (2005). Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys. J. Virol. 79: 5516-5528 [Abstract] [Full Text]  
  • BLANEY, J. E. JR., HANSON, C. T., FIRESTONE, C.-Y., HANLEY, K. A., MURPHY, B. R., WHITEHEAD, S. S. (2004). GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES. Am J Trop Med Hyg 71: 811-821 [Abstract] [Full Text]  
  • Pletnev, A. G., Putnak, R., Speicher, J., Wagar, E. J., Vaughn, D. W. (2002). From the Cover: West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. USA 99: 3036-3041 [Abstract] [Full Text]  
  • Hanley, K. A., Lee, J. J., Blaney, J. E. Jr, Murphy, B. R., Whitehead, S. S. (2002). Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes. J. Virol. 76: 525-531 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»